Background. Partial Risk Adjustment in Surgery (PRAiS), a risk model for 30-day mortality after children's heart surgery, has been used by the UK National Congenital Heart Disease Audit to report expected riskadjusted survival since 2013. This study aimed to improve the model by incorporating additional comorbidity and diagnostic information.
Background. Partial Risk Adjustment in Surgery (PRAiS), a risk model for 30-day mortality after children's heart surgery, has been used by the UK National Congenital Heart Disease Audit to report expected riskadjusted survival since 2013. This study aimed to improve the model by incorporating additional comorbidity and diagnostic information.
Methods. The model development dataset was all procedures performed between 2009 and 2014 in all UK and Ireland congenital cardiac centers. The outcome measure was death within each 30-day surgical episode. Model development followed an iterative process of clinical discussion and development and assessment of models using logistic regression under 25 3 5 cross-validation. Performance was measured using Akaike information criterion, the area under the receiver-operating characteristic curve (AUC), and calibration. The final model was assessed in an external 2014 to 2015 validation dataset.
Results. The development dataset comprised 21,838 30-day surgical episodes, with 539 deaths (mortality, 2.5%). The validation dataset comprised 4,207 episodes, with 97 deaths (mortality, 2.3%). The updated risk model included 15 procedural, 11 diagnostic, and 4 comorbidity groupings, and nonlinear functions of age and weight. Performance under cross-validation was: median AUC of 0.83 (range, 0.82 to 0.83), median calibration slope and intercept of 0.92 (range, 0.64 to 1.25) and -0.23 (range, -1.08 to 0.85) respectively. In the validation dataset, the AUC was 0.86 (95% confidence interval [CI], 0.82 to 0.89), and the calibration slope and intercept were 1.01 (95% CI, 0.83 to 1.18) and 0.11 (95% CI, -0.45 to 0.67), respectively, showing excellent performance.
Conclusions. A more sophisticated PRAiS2 risk model for UK use was developed with additional comorbidity and diagnostic information, alongside age and weight as nonlinear variables. A pproximately 3,500 children under 16 years of age have heart surgery each year in the United Kingdom [1] and since 2000 all cardiac centers have contributed procedure data to the National Congenital Heart Disease Audit (NCHDA). Center-specific mortality outcomes for individual procedures have been published online since 2007 by the NCHDA [2] .
With the accumulation of registry based data, consensus-based risk stratification methods for pediatric cardiac surgery, such as the Risk Adjusted classification for Congenital Heart Surgery (RACHS-1) [3] and Aristotle [4] methods, have given way to empirical approaches including the Society of Thoracic Surgeons-European Association of Cardiothoracic Surgery (STS-EACTS) score [5] . The Partial Risk Adjustment in Surgery (PRAiS) risk model for 30-day mortality after pediatric cardiac surgery was developed in 2011, using 10 years of UK audit data [6, 7] implement it for routine monitoring [8] , and has been used by the NCHDA since 2013.
The PRAiS model incorporated information about procedure (29 categories), cardiac diagnosis (3 risk categories), number of functioning ventricles, age category (neonate, infant, child), age, and weight as continuous variables, as well as presence of a non-Down syndrome comorbidity and whether surgery was performed on cardiopulmonary bypass. As the PRAiS model began to be used to monitor outcomes, data quality for information previously collected but not actively used (eg, comorbidity and diagnosis codes) improved rapidly.
This study uses recent NCHDA data to improve the PRAiS model by incorporating more detailed information about comorbid conditions, acuity, and diagnosis. In this paper, the original model will be referred to as the PRAiS1 model and the new model as the PRAiS2 model.
Material and Methods
Data NCHDA data are subject to external validation and survival status is independently verified for patients resident in England or Wales by the Health and Social Care Information Centre.
The development dataset consisted of all pediatric cardiac procedures performed in the United Kingdom and Ireland from April 2009 to March 2014. Records were excluded if the patient was over 16 years of age; the procedure was noncardiac, nonsurgical, or minor; or it was performed at 1 small-volume center that ceased pediatric cardiac surgery in 2010.
In February 2016, the NCHDA provided a further year of procedure data for April 2014 to March 2015: this was used as an external validation dataset. The final model was recalibrated on all data from 2009 to 2015.
The unit of analysis was a 30-day surgical episode [6, 7] . For each patient an episode started with their first surgical procedure. Any further surgical procedures that the same patient underwent within 30 days of this first procedure were not included. The next surgical procedure recorded for the same patient more than 30 days after the first surgical procedure was treated as the start of a new, independent 30-day episode. The outcome measure was death within each 30-day surgical episode. Where the life status at 30 days could not be determined, discharge status prior to 30 days was used.
Data Cleaning
Duplicate records and inconsistencies in age or life status within or across records relating to the same patient were identified, removed, or resolved.
Episodes in the development dataset with an absolute weight-for-age Z-score of 5 or over or with a weight judged to be infeasible by a clinician or a missing weight were assigned the mean weight-for-age. To mimic prospective use, no adjustments of weight were made when an episode was being used for validation.
Risk Factors Considered
PROCEDURES. A Specific Procedure hierarchical algorithm was developed by the NCHDA to sort submitted individual European Pediatric Cardiac Code (EPCC) [9] codes into a Specific Procedure category. We used the Specific Procedure Algorithm Coding v5.05 from May 2016 [10] , which includes 49 Specific Procedures.
In the PRAiS1 model, only bypass and nonbypass surgical procedures were included. For the PRAiS2 model the hybrid procedure for hypoplastic left heart syndrome (HLHS) [11] was also incorporated. DIAGNOSIS. A scheme that maps the individual EPCC diagnosis codes recorded for each episode to 1 of 29 hierarchical diagnostic categories was used [12, 13] (see Supplemental Material 1 for details). An increase in the number of diagnostic groupings from the 3 broad groups used in the PRAiS1 model [6] was explored.
A surgical episode was determined to relate to a patient with a functionally univentricular heart if they had a diagnosis or procedure code suggesting single-ventricle physiology.
COMORBIDITY. Each episode can have several different EPCC comorbidity codes recorded. Possible ways to include more comorbidity information were explored as discussed in detail in Brown and colleagues [14] . AGE AND WEIGHT. The association of both age and weight with the log odds of mortality is nonlinear. The PRAiS1 model used a continuous linear weight and age and neonate, infant and child age bands as categorical risk factors [6] . However, this resulted in unrealistic jumps in predicted risk at age band boundaries. To better capture this nonlinearity and explore any interaction between age and weight, we considered age and weight categories in combination with continuous age, weight, and weightfor-age Z-scores similarly to the STS model [15] , cubic splines [16] , and fractional polynomials [17] .
Model Development Strategy
As raw mortality rate is low (<3%), there is a practical limit to how many parameters can be reasonably included in an empirical risk model. A common rule of thumb is that overfitting is alleviated if the number of deaths in the dataset is at least 10 times larger than the number of parameters [18] . This gave a practical limit of about 40 parameters that could be included in the PRAiS2 model, necessitating a trade-off between adding comorbidity and diagnostic information and reducing Specific Procedure information, particularly given the increase in the number of individual procedure categories included in the Specific Procedure algorithm, including several lower volume categories.
An expert advisory panel from 5 hospitals comprising 3 surgeons (V.T., D.A., D.J.B.), 2 cardiologists (K.E., R.C.F.), 2 intensivists (K.L.B., S.T.), and 2 data management experts (T.W., J.S.) was assembled to consider the relative importance of comorbidities and potential trade-offs in included risk factors.
Analysis
Groupings of comorbidity codes were determined using the clinical and coding expertise of the panel, informed by univariate and multivariate associations of candidate comorbidity groupings with mortality [14] .
Classification and regression tree analysis [19] was used to define initial broader groupings of procedure and diagnostic categories, taking into account patient age and observed mortality. These groups were adjusted iteratively after consultation with the clinical expert panel and testing of the performance of the resultant risk models under cross-validation. The expert panel provided advice on procedures and diagnoses where the observed mortality was not considered representative of the risk, or where procedures or diagnoses that were qualitatively different should not be combined in a single group.
Multiple logistic regression was used within the Stata statistical software package (StataCorp 2013, Release 13, College Station, TX).
Comparison of candidate models was performed within the development dataset using the area under the receiver-operating characteristic curve (AUC) and Akaike information criterion.
Fivefold cross-validation repeated 25 times (25 Â 5 crossvalidation) was then carried out [20] , with the data splits stratified by year and unit to ensure a representative case mix. The median and range of the AUC over the 25 repeats of the cross-validation was calculated [21] . The calibration slope (b) and intercept (a) were estimated in each of the 125 test sets [22] , and the median and range were calculated. b
gives an indication of whether the model is underfitting or overfitting the data, and a indicates whether the model is underpredicting or overpredicting deaths. If a model is perfectly calibrated, b ¼ 1 and a ¼ 0 [23] .
A comparison was also made to the PRAiS1 model recalibrated on the development dataset to ensure that improvements in model performance were achieved.
Finally, any episodes that had particularly large leverage or influence [16] were investigated to see whether they were genuine outliers or data errors.
Performance of the final selected model is reported as the median and range of the AUC, calibration slope, and calibration intercept over the cross-validated test sets and the AUC, calibration slope, and intercept are reported with 95% confidence intervals (CI) in the external validation set.
Results
The cleaned development dataset comprised 21,838 30-day surgical episodes, of which 539 resulted in death within 30 days (mortality rate, 2.5%). Figure 1 gives a summary of the records excluded from the development dataset. Missing data was not a significant issue [6] -fewer than 0.6% of records were missing a relevant field.
Of the final 21,838 episodes, 5 episodes had their weights adjusted from grams to kilograms and 33 episodes with anomalous or missing weight were assigned the mean weight for their age.
For 3,165 episodes (14.5%), the discharge status prior to 30 days was used to generate outcome as certified life status was unavailable (overwhelmingly for overseas patients lacking a UK national health identifier).
The validation dataset comprised 4,207 episodes with 97 deaths (mortality rate, 2.3%). To mimic prospective use, no adjustments to missing or anomalous weights were made. For 724 episodes (17.2%), the discharge status prior to 30 days was used as a proxy for 30-day life status.
New Comorbidity, Procedure, and Diagnosis Groups
The comorbidity factors included in the model were: congenital comorbidity; acquired comorbidity; severity of illness; and additional cardiac risk factor.
The 49 specific procedures were combined into 15 procedure groups as well as a no Specific Procedure category; these are shown in Table 1 . The 29 diagnosis categories were combined into 11 diagnosis groups; these are shown in Table 2 .
The groups were determined on a basis of complexity, risk, age, any association between procedures and diagnosis, and the clinical validity of the groups. For instance, arterial shunts, which are performed on a wide variety of patients, were retained as a separate group.
The PRAiS2 model includes similar additional risk factors to the STS model variables [24] of noncardiac congenital anatomic abnormality, chromosomal abnormality or syndrome, and preoperative factors. The treatment of procedural and diagnostic information in the 2 models differs, with the STS model including a separate intercept parameter for each combination of age group and primary procedure, and no diagnostic information. The PRAiS2 procedural and diagnostic groups were determined accounting for interactions between procedures, diagnoses, risk and age, and clinical validity.
Other Risk Factors
The HLHS hybrid approach procedures were included in the nonbypass procedure category.
Fractional polynomials of the form ax þ b ffiffi ffi x p were best able to capture the relationship of both age and weight with mortality, and were much preferred by the clinical expert panel to avoid artifactual changes in estimates of risk at age or weight category boundaries. Similarly to the STS model, age-for-weight Z-scores did not improve the model.
Mortality has been falling in the United Kingdom and Ireland [25] , with particular reduction post-2012. Similar to the PRAiS1 model, a binary post-2012 epoch variable was included.
Once the final model risk factors had been chosen, shrinkage [22] was considered. There was little indication of overfitting and shrinkage did not significantly improve calibration under cross-validation.
Final Risk Model
The final risk model was a logistic regression model with the following variables: age; weight; procedure group; diagnosis group; procedure type; univentricular heart indicator; congenital comorbidity indicator, acquired comorbidity indicator; severity of illness indicator; additional Table 3 . As the Specific Procedure and diagnosis groups are grouped by age and similarity as well as risk, the odds ratios compared to the reference group are not informative and so are not included. Under cross-validation, the model had a median AUC of 0.83 (range, 0.82 to 0.83), showing excellent discrimination. There was only slight evidence of overfitting, with a median calibration slope of 0.92 (range, 0.64 to 1.25) and median calibration intercept of -0.23 (range, 1.08 to 0.85; perfect calibration slope ¼ 1 and intercept ¼ 0), indicating slight underprediction. The recalibrated PRAiS1 model had a median AUC of 0.80 (range, 0.80 to 0.81), and a median calibration slope and intercept of 0.90 (range, 0.63 to 1.31) and -0.29 (range, -1.15 to 1.06), respectively, and so was outperformed by the PRAiS2 model across all measures.
In the external validation set, there were 97 observed deaths in the test set compared with 89 predicted. The AUC was 0.86 (95% CI, 0.82 to 0.89) (Fig 2) and the calibration slope and intercept were 1.01 (95% CI, 0.83, 1.18) and 0.11 (95% CI, -0.45 to 0.67), respectively. The model 
Comment
This study has produced an improved PRAiS risk model by using more information about comorbidity and diagnosis while reducing the total number of model parameters from 38 to 36. Two independent risk models (STS and PRAiS) using different national datasets have now resulted in similar risk factors and a similar methodology of close iterative interaction between analysts and experts from the clinical community.
The clinical validity of the risk factors to be included in the PRAiS2 model was discussed in considerable detail by the expert panel, as were known case mix differences between centers. In particular, the clinical experience of the panel added value to the empirical evidence to define the final comorbidity and additional risk factors and the final broader Specific Procedure and diagnosis groupings. The close involvement of the expert panel representing many hospitals and different specialties was very successful, allowed careful consideration of how individual codes have been, and will be used by centers in practice and built trust in the final model within the clinical community.
Despite the excellent performance of the PRAiS2 model, there is 1 case mix feature present within the model that needs highlighting: risk for the HLHS hybrid procedure, generally performed on the sickest patients, is underpredicted. Of the 60 HLHS hybrid procedures in the 2009 to 2015 data, there were 10 observed deaths but only 6 predicted deaths. This additional risk cannot yet be well captured in the PRAiS2 model due to low case volume. Additionally, this procedure has predominantly been performed at 1 center, which could therefore be unfairly affected in the prospective national audit. The expert panel recommended including HLHS hybrid procedures within the PRAiS2 model despite these issues as this procedure is expected to become more common. It has been proposed to the NCHDA steering committee that the PRAiS2 model for future national audit is run twice on data including and excluding hybrid HLHS procedures in turn so that this effect can be accounted for. As this procedure becomes more common, the PRAiS2 model will be recalibrated to better reflect this particular risk.
This case mix feature highlights the importance of the continual process of use and collaborative development of this and similar models, as the quality and quantity of the data available increases and as clinical practice evolves.
